Legend Biotech (NASDAQ:LEGN) Azioni, Quote.MetaTitle.unusual-options

Legend Biotech

Legend Biotech Corporation - American Depositary Shares

Legend Biotech Corp

Abivax

Arcellx

Akero Therapeutics

Alkermes

Apogee Therapeutics

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

Caris Life Sciences

Cogent Biosciences

CRISPR Therapeutics

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Grifols, S.A. - American Depositary Shares

Grifols

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Krystal Biotech

Kymera Therapeutics

Merus

Metsera

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Nuvalent

Vaxcyte

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

PTC Therapeutics

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

TG Therapeutics

Viking Therapeutics

Legend Biotech (LEGN) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Vendite allo scoperto

Rapporto azionario

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Comments

Legend Biotech Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO